Apple AirPods Pro 4 Launches: Real-Time Translation + Blood Glucose Monitoring, Starting at 2,799 RMB

Overview

Apple released the new AirPods Pro 4 at WWDC2027. The biggest highlight is the self-developed H4 chip, achieving the two major functions of on-device real-time translation and continuous blood glucose monitoring for the first time.

Starting price 2,799 RMB, 15% higher than previous generation. First-day pre-orders still exceeded 2 million units.

Core Upgrades

Real-Time Translation

AirPods Pro 4 supports 40-language instant translation. Both conversation parties wearing one earphone each enables barrier-free communication. Translated content directly voice-broadcasted with latency under 800ms.

More importantly, translation is completely done on-device, not through cloud—this is significant for privacy-sensitive scenarios like business negotiations.

Continuous Blood Glucose Monitoring

Apple partnered with Abbott to integrate continuous glucose monitoring (CGM) module into the earphone charging case. Wearing special ear hook accessories enables 7 days × 24 hours continuous blood glucose monitoring, syncing data to Apple Health.

This is significant good news for diabetic patients. Apple officially enters the chronic disease management market.

Other Upgrades

• Sound quality: Adaptive spatial audio upgraded, can real-time tune based on ear canal shape
• Battery life: 8 hours in active noise cancellation mode, 32 hours total with charging case
• Water resistance: IPX8 waterproof, wearable while swimming

Competitive Landscape

Samsung immediately announced Galaxy Buds Pro 4 will also launch translation feature at 1,999 RMB. But industry insiders point out Apple's H4 chip on-device AI inference capability still leads the industry by at least 18 months.